Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Shell Q1 Profit Surges to Two-Year High as Dividend Rises Despite War-Driven Debt Pressure 
BHP Attracts AI-Focused Investors as Copper Demand Surges 
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook 
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain 
Volvo Car Sales Drop 10% in Early 2026 Despite Growth in Electric Vehicles 
China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
Agentic AI Boom to Drive Massive Growth in CPU Market, UBS Says 
Arm Stock Drops Despite Strong AI Chip Demand and Earnings Beat 
UOB Q1 Profit Meets Expectations as Loan Growth Offsets Lower Interest Rates 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
GAITHERSBURG, Md., May 01, 2018 -- OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report financial results for the three months ended March 31, 2018 after close of the U.S. financial markets on Tuesday, May 8, 2018. OpGen’s management team will host a live conference call and webcast at 4:30 p.m. Eastern time to discuss the Company’s financial results and business progress.
Dial-in Information
U.S. Dial-In Number: (888) 883-4599
International Dial-In Number: (484) 653-6821
Conference ID: 1082196
Replay Dial-in Information
U.S. Dial-In Number: (855) 859-2056
International Dial-In Number: (404) 537-3406
Conference ID: 1082196
Following the conclusion of the conference call, a replay will be available through May 14, 2018. The live, listen-only webcast of the conference call may also be accessed by visiting the investors section of the Company’s website at http://ir.opgen.com. A replay of the webcast will be available after the conclusion of the call and will be archived on the Company’s website for 90 days.
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. For more information, please visit www.opgen.com.
OpGen Contact:
Michael Farmer
Vice President, Marketing
(240) 813-1284
[email protected]
[email protected]
Investor Contacts:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
[email protected]
or
Bruce Voss
(310) 691-7100
[email protected]
